Directed Therapies in Anaplastic Lymphoma Kinase-rearranged Non-small Cell Lung Cancer.

Abstract:

:Anaplastic lymphoma kinase (ALK) rearrangements were first implicated as driving mutations in non-small cell lung cancer in 2007. Since then, a number of novel, small-molecule inhibitors directed against the ALK receptor have demonstrated superiority over standard chemotherapies in the treatment of ALK rearrangement-positive lung cancer. Of considerable importance when considering such therapies is the ability of each to overcome mutations conferring acquired resistance, as well as penetrate the central nervous system (CNS), the most common site of metastasis and traditionally the most difficult to breach. Herein is a review of the efficacy, indications, and degree of CNS penetration for the ALK-targeting agents crizotinib, ceretinib, alectinib, brigatinib, and lorlatinib, as well as a summary of ongoing clinical trials comparing these drugs.

journal_name

Anticancer Res

journal_title

Anticancer research

authors

Millett RL,Elkon JM,Tabbara IA

doi

10.21873/anticanres.12815

subject

Has Abstract

pub_date

2018-09-01 00:00:00

pages

4969-4975

issue

9

eissn

0250-7005

issn

1791-7530

pii

38/9/4969

journal_volume

38

pub_type

杂志文章,评审
  • Phase II Trial of Erlotinib in Elderly Patients with Previously Treated Non-small Cell Lung Cancer: Results of the Lung Oncology Group in Kyushu (LOGiK-0802).

    abstract:BACKGROUND:As the incidence of lung cancer in the elderly is increasing worldwide, there exists a need to develop a clinically effective, less toxic therapy for this patient population. Although erlotinib has shown proven effectiveness against non-small cell lung cancer (NSCLC), few studies have prospectively investiga...

    journal_title:Anticancer research

    pub_type: 杂志文章,多中心研究

    doi:

    authors: Yamada K,Azuma K,Takeshita M,Uchino J,Nishida C,Suetsugu T,Kondo A,Harada T,Eida H,Kishimoto J,Eriguchi G,Takayama K,Nakanishi Y,Sugio K

    更新日期:2016-06-01 00:00:00

  • Evaluation of the two intraoperative examination methods for sentinel lymph node assessment: a multicentric and retrospective study on more than 2,000 nodes.

    abstract:BACKGROUND:Intraoperative frozen section (FS) and imprint cytology (IC) are currently used to detect sentinel lymph node (SLN) metastasis, allowing for complete dissection when necessary. MATERIALS AND METHODS:A 2-year retrospective chart review was performed for patients who underwent SLN procedure in five French hos...

    journal_title:Anticancer research

    pub_type: 杂志文章,多中心研究

    doi:

    authors: Arlicot C,Louarn AL,Arbion F,Leveque J,Lorand S,Kinn J,Chaze B,Garrigue A,Body G

    更新日期:2013-03-01 00:00:00

  • Stimulation by estrogen and progesterone of the in vivo growth of transformed murine Leydig cells only at the limited early phase of growth.

    abstract::B-1 F is a cell line established from estrogen-responsive murine Leydig cell tumor and maintained in vitro. We investigated the effects of steroid hormones on the growth of tumors produced by the inoculation of B-1 F cells into mice. When tumor tissues were transplanted into castrated male mice, injections of estradio...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Yamamoto T,Li I,Uchida N,Nishizawa Y,Yamamoto R,Terada N,Taniguchi H,Matsumoto K,Sato B

    更新日期:1992-09-01 00:00:00

  • Inhibition of angiogenesis and tumorigenesis, and induction of dormancy by p53 in a p53-null thyroid carcinoma cell line in vivo.

    abstract::Our recent in vitro findings for suppression of thrombospondin-1 (TSP1; an antiangiogenic factor) expression by wild-type (wt) p53 in a p53-null thyroid carcinoma cell line, FRO, prompted us to investigate the in vivo effect of exogenous wt-p53 and TSP1 expression on tumor growth and angiogenesis of FRO xenografts in ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Nagayama Y,Shigematsu K,Namba H,Zeki K,Yamashita S,Niwa M

    更新日期:2000-07-01 00:00:00

  • Her2 expression on disseminated tumor cells from bone marrow of breast cancer patients.

    abstract:BACKGROUND:The presence of cytokeratin (CK)-positive cells in the bone marrow (BM) of breast cancer patients is an independent prognostic marker for long-term survival. While the exact nature of these cells remains under investigation, their persistence after chemotherapy is linked to decreased survival, making them a ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Becker S,Becker-Pergola G,Fehm T,Wallwiener D,Solomayer EF

    更新日期:2005-05-01 00:00:00

  • Bortezomib Causes ER Stress-related Death of Acute Promyelocytic Leukemia Cells Through Excessive Accumulation of PML-RARA.

    abstract:BACKGROUND/AIM:The success of proteasome inhibitors in therapy of multiple myeloma has led to their use for other malignancies. For the proteasome inhibitor bortezomib, combination therapies with histone deacetylase inhibitors, which up-regulate ubiquitin-proteasome system (UPS)-related enzymes, produce a beneficial ef...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Takenokuchi M,Miyamoto K,Saigo K,Taniguchi T

    更新日期:2015-06-01 00:00:00

  • Mutations of mitochondrial DNA as potential biomarkers in breast cancer.

    abstract:BACKGROUND:Alterations of mitochondrial DNA (mtDNA) have been found in cancer patients, therefore informative mtDNA mutations could serve as biomarkers for the disease. MATERIALS AND METHODS:The two hypervariable regions HVR1 and HVR2 in the D-Loop region were sequenced in ten paired tissue and plasma samples from bre...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Cai FF,Kohler C,Zhang B,Chen WJ,Barekati Z,Garritsen HS,Lenner P,Toniolo P,Zhang JJ,Zhong XY

    更新日期:2011-12-01 00:00:00

  • Identifying melanoma patients with 1-3 brain metastases who may benefit from whole-brain irradiation in addition to radiosurgery.

    abstract:BACKGROUND/AIM:To develop a tool for estimating the risk of developing new cerebral lesions in 69 melanoma patients receiving radiosurgery for 1-3 cerebral metastases. PATIENTS AND METHODS:Ten factors were investigated: lactate dehydrogenase (LDH), radiosurgery dose, age, gender, performance status, maximum diameter, ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Huttenlocher S,Sehmisch L,Schild SE,Blank O,Hornung D,Rades D

    更新日期:2014-10-01 00:00:00

  • Topotecan-induced alterations in the amount and stability of human DNA topoisomerase I in solid tumor cell lines.

    abstract:BACKGROUND:Human DNA topoisomerase I (topo 1) is an essential nuclear enzyme involved in vital cellular processes and the sole target of antitumor drugs of the camptothecin (CPT) family. The CPT derivative topotecan (Tpt, Hycamtin) is currently used in clinic, its effectiveness varying considerably for different types ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Devy J,Wargnier R,Pluot M,Nabiev I,Sukhanova A

    更新日期:2004-05-01 00:00:00

  • Induction of cell death by Doxorubicin in multicellular spheroids as studied by confocal laser scanning microscopy.

    abstract::In the present study the effects of the anticancer drug Doxorubicin (Dox) on necrosis development and cell lethality of multicellular DU-145 spheroids (MCS) were examined. Multicellular spheroids consist of a peripheral rim of proliferating cells, a inner shell of nonproliferating, quiescent cells and a central core o...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Wartenberg M,Acker H

    更新日期:1996-03-01 00:00:00

  • Augmented pro-apoptotic effects of TRAIL and proteasome inhibitor in human promonocytic leukemic U937 cells.

    abstract::TRAIL, Tumor necrosis factor-related apoptosis-inducing ligand), a member of the TNF family, is known to be cytotoxic for a high proportion of tumor cell lines. However, successful application of TRAIL in tumor therapy may depend on finding other agents that can potentiate its antitumor effects. The present study show...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Młynarczuk I,Hoser G,Grzela T,Stokłosa T,Wójcik C,Malejczyk J,Jakóbisiak M

    更新日期:2001-03-01 00:00:00

  • Neoadjuvant epirubicin/docetaxel (ET) concomitant chemotherapy for primary breast cancer with tumor diameter >=3.1 cm: results of the Kyushu ET therapy phase II trial.

    abstract:AIM:Neoadjuvant epirubicin/docetaxel (ET) combination chemotherapy was administered to breast cancer patients in order to investigate their clinical and pathological response. Moreover, the breast-conserving surgery (BCS) rate, disease-free (DFS) and overall survival (OS), safety profile and the correlation of biologic...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Nishimura R,Rai Y,Matsuo F,Anan K,Hara S,Imamura S,Itoyanagi N,Kato M,Okido M,Kudaka M,Ishikawa E,Kamada Y,Watanabe R,Shirouzu M,Mitsuyama S,Takamatsu Y,Tamura K

    更新日期:2012-08-01 00:00:00

  • Detection and clinical relevance of tumor cells in blood and bone marrow of patients with colorectal cancer.

    abstract::In colorectal cancer, the predictive value of the currently used staging method is limited. Therefore, many parameters have been studied to improve the prediction of final clinical outcome, including several aspects of the primary tumor that are associated with its aggressiveness and the capacity of the host response....

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Vlems FA,Wobbes T,Punt CJ,Van Muijen GN

    更新日期:2003-01-01 00:00:00

  • Randomised double blind placebo control study of adjuvant treatment with the metalloproteinase inhibitor, Marimastat in patients with inoperable colorectal hepatic metastases: significant survival advantage in patients with musculoskeletal side-effects.

    abstract:BACKGROUND:A double blind placebo RCT of adjuvant treatment of the matrix metalloproteinase inhibitor, Marimastat, in patients with unresectable colorectal liver metastases showed no significant effect on survival. There was a statistically significant survival advantage for the marimastat-treated patients with musculo...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: King J,Zhao J,Clingan P,Morris D

    更新日期:2003-01-01 00:00:00

  • Different Gene Expression and Activity Pattern of Antioxidant Enzymes in Bladder Cancer.

    abstract::The aim of this study was to evaluate the possible role in and contribution of antioxidant enzymes to bladder cancer (BC) etiology and recurrence after transurethral resection (TUR). We enrolled 40 patients with BC who underwent TUR and 100 sex- and age-matched healthy controls. The analysis was performed at diagnosis...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11387

    authors: Wieczorek E,Jablonowski Z,Tomasik B,Gromadzinska J,Jablonska E,Konecki T,Fendler W,Sosnowski M,Wasowicz W,Reszka E

    更新日期:2017-02-01 00:00:00

  • Modification of membrane permeability measured by Texas-Red during cell cycle progression and differentiation.

    abstract::Membrane permeability is a critical parameter which must be assessed in the course of new potential anticancer drug studies. Flow cytometry allows us to monitor the permeability status of living cells through the measurement of fluorochrome retention; conventionally this is done using fluorescein diacetate or Hoechst3...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Leonce S,Cudennec CA

    更新日期:1990-03-01 00:00:00

  • In Vitro Apoptosis Induction by Fenofibrate in Lymphoma and Multiple Myeloma.

    abstract:BACKGROUND/AIM:Recent innovations in the treatment of multiple myeloma have enriched our therapeutic repertoire regarding the treatment of multiple myeloma during the last decades. However, despite today's therapies many multiple myeloma (MM) patients experience relapse of disease and eventually remain incurable. Wnt/β...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11719

    authors: Schmeel LC,Schmeel FC,Schmidt-Wolf IGH

    更新日期:2017-07-01 00:00:00

  • Pharmacokinetics of therapeutic monoclonal antibodies used in oncology.

    abstract::This review presents the clinical pharmacokinetics of the marketed therapeutic monoclonal antibodies used in oncology. Aspects regarding absorption, tissue distribution, elimination as well as factors influencing pharmacokinetics, pharmacodynamics and kinetic interactions are also discussed. ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Levêque D,Wisniewski S,Jehl F

    更新日期:2005-05-01 00:00:00

  • Randomized Study of Postoperative Single Intravesical Instillation With Pirarubicin and Mitomycin C for Low-risk Bladder Cancer.

    abstract:BACKGROUND:To assess the prophylactic efficacy of postoperative single intravesical instillation with pirarubicin (THP) and mitomycin C (MMC) for low-risk non-muscle-invasive bladder cancer (NMBC). PATIENTS AND METHODS:A total of 103 clinically low-risk NMBC patients were preoperatively randomized into either THP (n=4...

    journal_title:Anticancer research

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.21873/anticanres.14535

    authors: Yamamoto S,Kageyama Y,Fujii Y,Aizawa T,Urakami S,Fukui I

    更新日期:2020-09-01 00:00:00

  • A correlative approach for the identification of antimutagens that demonstrate chemopreventive activity.

    abstract::Seventy natural and synthetic compounds were tested for potential to inhibit mutation induced by 7,12-dimethylbenz(a)anthracene (DMBA) in Salmonella typhimurium strain TM677. Results were compared with their ability to inhibit DMBA-induced preneoplastic lesions in a mouse mammary gland organ culture system. The respon...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Shamon LA,Chen C,Mehta RG,Steele V,Moon RC,Pezzuto JM

    更新日期:1994-09-01 00:00:00

  • Immunohistochemical study of cyclooxygenases in prostatic adenocarcinoma; relationship to apoptosis and Bcl-2 protein expression.

    abstract:BACKGROUND:Cyclooxygenase (COX) is a key enzyme in the conversion of arachidonic acid to prostaglandins and other eicosanoids. A recent report has indicated a selective COX-2 inhibitor resulted in increased apoptosis and down-regulated bcl-2 expression in the androgen-sensitive human prostate cancer cell. We investigat...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Tanji N,Kikugawa T,Yokoyama M

    更新日期:2000-07-01 00:00:00

  • HER2 Equivocal Status in Early Breast Cancer Is Not Associated with Higher Risk of Recurrence.

    abstract:AIM:The primary aim of the study was to assess the association between risk of recurrence and HER2 equivocal gene status through immunohistochemistry in patients with early breast cancer. PATIENTS AND METHODS:We retrospectively analyzed clinical and pathological data of 455 consecutive patients with early breast cance...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Criscitiello C,Bagnardi V,Viale G,Disalvatore D,Rotmensz N,Esposito A,Goldhirsch A,Curigliano G

    更新日期:2016-07-01 00:00:00

  • COX-2 inhibitor celecoxib suppresses tumor growth and lung metastasis of a murine mammary cancer.

    abstract:BACKGROUND:The antitumor growth and antimetastatic actions of celecoxib [a selective cyclooxygenase-2 (COX-2) inhibitor] were investigated in a metastatic murine mammary cancer model. MATERIALS AND METHODS:Mice bearing mammary tumors, developed after inoculation of syngeneic BALBIc mice with a mammary carcinoma cell l...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Yoshinaka R,Shibata MA,Morimoto J,Tanigawa N,Otsuki Y

    更新日期:2006-11-01 00:00:00

  • Inflammatory breast carcinoma: an immunohistochemical study using monoclonal anti-pHER-2/neu, pS2, cathepsin, ER and PR.

    abstract::Immunocytochemical assays were performed on frozen sections of inflammatory breast carcinomas (n = 22) using the following monoclonal antibodies (MoAb): anti-pHER2/neu, cathepsin, pS2, ER, PR and MoAb Ki67. The distribution of these proteins, known as prognostic indicators, was evaluated with an image analysis system ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Charpin C,Bonnier P,Khouzami A,Vacheret H,Andrac L,Lavaut MN,Allasia C,Piana L

    更新日期:1992-05-01 00:00:00

  • Lack of prognostic significance of neuroendocrine differentiation and stem cell antigen co-expression in resected early-stage non-small cell lung cancer.

    abstract:BACKGROUND:Neuroendocrine (NE) carcinomas of the lung exhibit expression of various stem cell antigens, and except for carcinoid tumours, carry a poor prognosis. Despite the fact that 10%-30% of all non-small cell lung carcinomas (NSCLC) which are not classified as NE carcinomas also show expression of NE markers, data...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Gottschling S,Jensen K,Herth FJ,Thomas M,Schnabel PA,Herpel E

    更新日期:2013-03-01 00:00:00

  • Discordance of MCM7 mRNA and its Intronic MicroRNA Levels Under Hypoxia.

    abstract:BACKGROUND:Intronic microRNAs (miRNAs) are considered to be transcribed using their host gene promoter. However, about one third of intronic miRNAs are predicted to have independent promoter elements. MATERIALS AND METHODS:Human breast cancer cells were cultured under normoxia or hypoxia, and expression levels of intr...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11769

    authors: Kondo H,Shimono Y,Mukohyama J,Tanaka Y,Shibuya N,Minami H,Kakeji Y,Suzuki A

    更新日期:2017-07-01 00:00:00

  • In vitro interaction of high-LET heavy-ion irradiation and chemotherapeutic agents in two cell lines with different radiosensitivities and different p53 status.

    abstract:BACKGROUND:To investigate the differences between two rat yolk sac tumor cell lines with different radiosensitivities and p53 status in sensitivity to high-LET heavy-ion beam and in sensitizing effect of etoposide or cisplatin in combination with heavy-ion beam. MATERIALS AND METHODS:NMT-1 (wild-type p53 cell) is a pa...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Takahashi T,Fukawa T,Hirayama R,Yoshida Y,Musha A,Furusawa Y,Ando K,Nakano T

    更新日期:2010-06-01 00:00:00

  • UGP in urogenital disorders: Egyptian experience.

    abstract::UGP (Urinary gonadotropin peptide) also know as urinary gonadotropin fragment (UGF) or the beta-core of hCG (c beta hCG), was identified as a peptide with a molecular weight of 10.5 kD, having the same amino acid sequence as the core section of the beta-subunit of human chorionic gonadotropin. UGP has been found in no...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: el-Ahmady O,Halim AB,Gad M,Walker R

    更新日期:1996-07-01 00:00:00

  • Expression of Nogo isoforms and Nogo-B receptor (NgBR) in non-small cell lung carcinomas.

    abstract:BACKGROUND:Nogo-B was recently shown to be involved in proliferation, apoptosis and invasiveness of cancer cells, whereas its specific receptor (NgBR) was found to be up-regulated in estrogen receptor-α positive breast cancer. No data are currently available concerning their expression in non-small cell lung carcinomas...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Pula B,Werynska B,Olbromski M,Muszczynska-Bernhard B,Chabowski M,Janczak D,Zabel M,Podhorska-Okolow M,Dziegiel P

    更新日期:2014-08-01 00:00:00

  • Tumour therapy with genes encoding apoptin and E4orf4.

    abstract::The aim of our study was to investigate whether apoptin and e4orf4 pro-apoptotic genes, transferred by means of electroporation, were suitable for gene therapy of tumours. The two genes were chosen for our study because the proteins they encode induce apoptosis in transformed cells only. The apoptin gene was synthesis...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Mitrus I,Missol-Kolka E,Plucienniczak A,Szala S

    更新日期:2005-03-01 00:00:00